| Net Cash Provided by (Used in) Operating Activities |
$21,901 |
USD |
-223% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$10,000 |
USD |
-233% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
45,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
4,450,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$31,901 |
USD |
-226% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$39,300 |
USD |
17% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$39,300 |
USD |
17% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$204,500 |
USD |
589% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |